Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Marks Electrical working to lift margins after FY profit decline

(Sharecast News) - Electricals and white goods online retailer Marks Electrical saw minimal revenue growth and a big decline in earnings over the 12 months to 31 March after replacing its business-wide legacy enterprise resource planning (ERP) system, and said it had a weak peak trading period. Revenues rose 2.6% year-on-year to £117.2m, as sales declines in the third quarter - impacted by the ERP switchover - were followed by a return to growth in the fourth.

"This improvement in underlying growth momentum, with a strong exit rate in March of 6.6%, provides us with the confidence to maintain our guidance for the year ahead," the company said.

Full-year adjusted EBITDA totalled £4.2m, down from £5.2m the previous year though in line with guidance for a figure "in excess of £4.0m".

"FY25 was a period of significant strategic change and progress and whilst the margin and growth rates were not at the higher levels seen in recent years, nor where I would like the business to be, I continue to be proud of the performance the team has delivered, whilst tackling the significant operational distractions brought about by the changes we decided to make," said chief executive Mark Smithson.

Looking ahead, the company said it is pivoting the business back to its "historically successful premium focus" in order to improve margins.

"This strategy is on-track and margins improved in the second half of FY25, despite a weak peak trading period. Our objective in FY26 is to continue to drive this sustainable margin recovery and this focus may be at the expense of revenue growth," the company said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.